Cerebral Cryptococcosis

Definition

  • Severe CNS fungal infections caused by the genus Cryptococcus ; includes meningitis and focal “cryptococcomas”

Clinical Features

Epidemiology

  • C. neoformans : ubiquitous in soil, bird excrement, compost

  • C. gattii : tropical/subtropical climates, North American western coast

    • Eucalyptus trees primarily

    • Primarily infects nonimmunocompromised persons

  • Most common CNS fungal infection in immunocompromised (primarily C. neoformans )

    • Increased incidence: alcoholism, sarcoidosis, corticosteroids, immunosuppression/autoimmune

  • First manifestation of AIDS in up to 70% of HIV-positive adults, rare in children

    • Two to seven per 1000 HIV-positive patients affected per year in the United States

Presentation

  • Inhaled spores

    • Most people clear infection

    • Delayed hypersensitivity reaction (positive skin test)

  • Pulmonary

    • Infiltrates, lymphadenopathy, effusions, cavitations

  • Hematogenous dissemination from lungs (most common route)

    • CNS, skin, myocardium, eyes (almost any organ)

    • Meningitis (tends to be basal)/encephalitis

    • Cryptococcoma: commonly seen in immunocompetent (usually C. gattii )

  • Subtle onset: relapsing/remitting with vague symptoms

    • Headache, fever, generalized discomfort, nausea and vomitting, meningismus, mental status changes, visual complaints

    • Seizures, focal neurologic deficits less commonly

  • Cerebrospinal fluid

    • CSF polymerase chain reaction (PCR) for diagnosis

    • Protein: normal to 500 mg/dL

    • Glucose: normal/mildly decreased

    • Pleocytosis (predominantly mononuclear)

  • Neurotropic: CSF is an excellent growth medium

Prognosis and Treatment

  • Mortality rate: 6% to 14% (with treatment)

  • High relapse rates

  • Amphotericin B and flucytosine

Pathology

Gross

  • Opaque/fibrotic meninges (especially base of brain/cerebellum) in nonimmunocompromised patients

  • Gelatinous-appearing cysts in the basal ganglia

  • Isolated cryptococcal abscess (cryptococcoma)

Histology

  • Encapsulated ovoid budding yeast (3 to 20 µm)

    • Capsule: clear halo on H&E

    • Sometimes confused with corpora amylacea

  • Meningitis with granulomatous inflammation (nonimmunocompromised)

    • Spherical organisms with capsule found in subarachnoid space

    • Can lead to hydrocephalus/cerebral edema

    • Immunocompromised patients: minimal inflammation/necrosis until late stage of the disease

  • Intraparenchymal lesions

    • Cystic “soap bubbles”/solid nodules

    • Basal ganglia most common location

    • Perivascular “tubercles”: 3 mm or smaller

  • Cryptococcomas (“Torulomas”)

    • Immunocompetent hosts usually

    • Mass lesions, sometimes granulomatous

    • May involve meninges, ependyma, choroid plexus, parenchyma

Immunopathology/Special Stains

  • Mucicarmine, Gomori methenamine silver (GMS), Alcian blue

Main Differential Diagnoses

  • Other mass lesions

    • Toxoplasmosis, lymphoma, neoplasm

  • Intracranial hemorrhage

  • Sarcoidosis

  • Meningitis/encephalitis/abscess (e.g., bacterial/mycobacterial/parasitic/candida)

  • Other HIV encephalitides

Fig 1, Cerebral cryptococcosis. The presence of multifocal gelatinous cysts within the bilateral basal ganglia is a classic pattern of CNS involvement by Cryptococcus in the immunocompromised host.

Fig 2, Cerebral cryptococcosis. At low magnification, numerous cryptococcal organisms are contained within a circumscribed lesion with associated granulomatous reaction.

Fig 3, Cerebral cryptococcosis. At high magnification (H&E), organisms are round and have a distinctive capsule.

Fig 4, Cryptococcal meningitis. An inflammatory reaction may be limited or absent in the immunocompromised host, and extensive organisms may be seen (mucicarmine stain).

Fig 5, Cerebral cryptococcosis. Cryptococcal organisms fill the subarachnoid space and produce characteristic gelatinous cysts (mucicarmine stain).

Aspergillosis

Definition

  • Inhaled spores/conidia of Aspergillus species (ubiquitous mold) cause an array of disease manifestations ranging from allergic reactions to disseminated aspergillosis; angioinvasive

Clinical Features

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here